Sage Therapeutics Inc (SAGE) — Cash Flow Reinvestment Rate
Sage Therapeutics Inc (SAGE) has a Cash Flow Reinvestment Rate of 0.05x as of December 2020, reinvesting $45.52 Million (capex $1.00K plus investments $45.52 Million) from operating cash flow of $1.01 Billion. Explore Sage Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sage Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sage Therapeutics Inc across 1 annual periods. Also explore SAGE total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sage Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sage Therapeutics Inc. For live market cap and broader valuation context, see how much is Sage Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.67x | $443.37 Million | $664.28 Million | $345.00K | — |